<DOC>
	<DOCNO>NCT00110240</DOCNO>
	<brief_summary>This study conduct United States . The purpose study assess safety effectiveness vildagliptin , unapproved drug , compare acarbose lower overall blood glucose level people type 2 diabetes previously treat drug therapy lower blood sugar .</brief_summary>
	<brief_title>Efficacy Safety Vildagliptin Compared Acarbose Drug Naive Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Not currently drug therapy type 2 diabetes Body mass index ( BMI ) range 2040 Blood glucose criterion must meet Pregnancy lactation Type 1 diabetes Evidence significant diabetic complication Evidence serious cardiovascular condition Laboratory value abnormality define protocol Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>vildagliptin</keyword>
</DOC>